Skip to main content

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases. Through its affiliation with the University of Zurich, the editorial mandate of the "European Heart Journal" and as the seat of the "Foundation for Cardiovascular Research", the Zurich Heart House is one of the most important cardiology research and education centres in Europe.

The Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

ZHH News


Back to the cradle: Prof. Thomas F. Lüscher is declared Robert L. Frye lecturer at the Mayo Clinic

Prof. Thomas F. Lüscher gives the 25th Robert L. Frye lecture at the Mayo Clinic, Rochester and shares his views on The Future of Cardiology. At this prestigious occasion, Prof. Lüscher returns to the place where he started his career. 


FAN Award for Medicine and Natural Sciences: Congratulations to Florian Wenzl!

Florian Wenzl is honored with a FAN Award for his original research on personalized heart attack treatment.

Read more here!


Winner of the European Society of Cardiology Young Investigator Award 2023 in Basic Science: Congratulations to Dr. Srividya Velagapudi!

For her outstanding scientific work on Sirtuin-1 and the low-density lipoprotein metabolism Dr. Srividya Velagapudi was declared Winner of the highly prestigious European Society of Cardiology Young Investigator Award in Basic Science.

Cardiology News


Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: A Prospective Analysis From the VITA Cohort Study

Long noncoding RNAs (lncRNAs) are involved in diabetogenesis in experimental models, yet their role in humans is unclear. The paper investigates whether circulating lncRNAs associate with incident type 2 diabetes in older adults.

Read full article (Diabetes Care 2023;46(6):1239–1244)


Artificial Intelligence and Deep Learning: Wittgenstein beats Plato

Artificial intelligence (AI) is becoming increasingly important in cardiovascular medicine - but how does AI learn? Thomas F. Lüscher and Florian A. Wenzl provide their perspective in the European Heart Journal


Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes

The Global Registry of Acute Coronary Events (GRACE) risk score, a guideline-recommended risk stratification tool for patients presenting with acute coronary syndromes (ACS), does not consider the extent of myocardial injury.

Read full article (JAMA Cardiology, August 2023)